Tech Company Financing Transactions
Aragon Pharmaceuticals Funding Round
The Column Group and OrbiMed participated in a $8 million Series A funding round for Aragon Pharmaceuticals. The round was announced on 5/21/2009.
Transaction Overview
Company Name
Announced On
5/21/2009
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
The Column Group (Lead Investor)
Proceeds Purpose
The company said the funding will be used to develop new small molecule drugs for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12780 El Camino Real 301
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Email Address
Overview
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Paul Cleveland
Chief Medical Officer
Isan Chen
President
Richard Heyman
VP - Bus. Development
Angie You
Browse more venture capital transactions:
Prev: 5/20/2009: Pathway Medical Technologies venture capital transaction
Next: 5/21/2009: Avid Radiopharmaceuticals venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs